Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Finn Wisløff

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 27, 2007
[Epoetin in cancer treatment--the end of the game?]Finn Wisløff
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 19, 2003
[Financing of enzyme treatment in Gaucher disease]Finn Wisløff
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 9, 2004
[Total survival as quality indicator]Finn Wisløff
Thrombosis Research|August 13, 2004
Evidence-based treatment of the antiphospholipid syndrome: I. Pregnancy failureFinn Wisløff, Mark Crowther
Thrombosis Research|March 29, 2005
Effect of subcutaneous administration of dalteparin on lupus anticoagulant assaysSigurd Liestøl, Finn Wisløff
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 19, 2003
[Gaucher disease]Per Ole Iversen, Finn Wisløff
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 16, 2008
[Research ethics and University of Oslo]Haakon Breien Benestad, Finn Wisløff
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 28, 2003
[National guidelines for treatment of chronic myelogenous leukemia]Finn Wisløff, Lorentz Brinch, Jens Hammerstrøm
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 17, 2008
[Is registration of multiple myeloma in the Norwegian Cancer Registry good enough?]Martin Aasbrenn, Frøydis Langmark, Finn Wisløff
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 30, 2010
[Close cooperation, but not oversteering]Erlend B Smeland, Frode Vartdal, Finn Wisløff
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 27, 2007
[Epoetin in cancer treatment--the end of the game?]Finn Wisløff
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 19, 2003
[Financing of enzyme treatment in Gaucher disease]Finn Wisløff
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 9, 2004
[Total survival as quality indicator]Finn Wisløff
Thrombosis Research|August 13, 2004
Evidence-based treatment of the antiphospholipid syndrome: I. Pregnancy failureFinn Wisløff, Mark Crowther
Thrombosis Research|March 29, 2005
Effect of subcutaneous administration of dalteparin on lupus anticoagulant assaysSigurd Liestøl, Finn Wisløff
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 19, 2003
[Gaucher disease]Per Ole Iversen, Finn Wisløff
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 16, 2008
[Research ethics and University of Oslo]Haakon Breien Benestad, Finn Wisløff
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 28, 2003
[National guidelines for treatment of chronic myelogenous leukemia]Finn Wisløff, Lorentz Brinch, Jens Hammerstrøm
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 17, 2008
[Is registration of multiple myeloma in the Norwegian Cancer Registry good enough?]Martin Aasbrenn, Frøydis Langmark, Finn Wisløff
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 30, 2010
[Close cooperation, but not oversteering]Erlend B Smeland, Frode Vartdal, Finn Wisløff
Pageof 3